Brigitte Drees

CEO & Board Member, Pivot Park | PharmaNL

Elise de Reus

Co-Founder, Cradle

Wiro Niessen

Dean, Board Member & Professor, UMCG

Marianne Verhaar

Professor of Experimental Nephrology, UMC Utrecht

Stanleyson Hato

Team Lead Life Sciences & Health, Invest-NL

Erik van den Berg

CEO, MemoTherapeutics AG

Carmen van Vilsteren

Chair, Health~Holland

Eliane Schutte

CEO, Xeltis

Hans Schikan

Top Team Member Life Sciences & Health, Health~Holland

Kasper Roet

CEO & Founder, QurAlis

Maroeska Rovers

Scientific Director TechMed Centre, University of Twente

Sascha Oliver Bucher

Co-Founding Partner, Forty51 Ventures

Mark Quick

Partner, Flerie

Jérôme Van Biervliet

Managing Director, VIB

Stefan Volk Jovinge

President of Research, Education, Development and Innovation, Skåne University Hospitals

Willem Mulder

Professor of Precision Medicine, Radboudumc & TU/e

Anant Murthy

Co-Founder and Board Member, Avanzanite Bioscience

Eline van Beest

CEO, Hybridize Therapeutics & Operational Partner, Thuja Capital

Yael Weiss

CEO, Mahzi Therapeutics

Ed Kaye

CEO & Director, Stoke Therapeutics

Noortje Bax

Chair, 4TU.Health Centre

Paul Korte

Board Member, FAST

Brian Woolhouse

Managing Director, MSD Netherlands

Eleanor Price

Associate, Thuja Capital

Sangbreeta Moitra

TEDX-awarded Keynote Speaker & Executive Leadership Coach

Pernilla Isberg

Director, AstraZeneca BioVentureHub

Inge Jedema

Co-lead Cell and Gene Therapy, Oncode Accelerator

Jessie van Buggenum

Manager Thematic Cluster ATMPs, Biotech Booster

Wim van Hartingsveldt

Business Development Manager, TNO

Willem van den Brink

Senior Scientist Digital Biomarkers, Health & Work, TNO

Kevin Witlox

Scientist Innovator, TNO

Jayeeta Sengupta

Program Manager, TNO

Natallia Uzunbajakava

Senior Scientist, TNO

Michiel Oderwald

Senior Business Developer, TNO

Kinga Matuła

CEO, QurieGen

Eva-Karin Gidlund

Chief Business Officer, NorthX Biologics

Koenraad Wiedhaup

CEO, Leyden Labs

Barend Bouma

Dutch and European Patent Attorney AP, NLO

Mark Wijsman

Chair

Robert-Jan van der Vorm

Director Corporate Finance, Van Lanschot Kempen

Jessica Vermeulen

Vice President, Lymphoma & Leukemia Disease Area Stronghold Leader, Johnson & Johnson

Leoni Delsink

Portfolio Manager, Cooperative VGZ 

Oscar Smit

CEO, Progress - Experts in Life Sciences

Laura Duran

International Relations Manager, Health~Holland

Meta Roestenberg

Director, INFECTA & Professor in Vaccine Development, LUMC

Debby Vermeer-Kruijsen

Co-Workstream Leader & Executive Board Member, Oncode Accelerator

Djamel Deken

Senior Director Business Development, HALIX

Hanneke van Laarhoven

Professor, Head of the Department of Medical Oncology, Amsterdam UMC

Lizan Bloemsma

Post-Doctoral Fellow, Amsterdam UMC

Ruben Postel

CSO & Founder, Sapreme Technologies

Eric Schmitt

Principal, Sinefield

Sarah Opitz

Science Writer & Editor, Sarah Opitz BV

Cheryl Zimberlin

Fund Manager, Oncode Bridge Fund

Anthe Janssen

Assistant Professor, Leiden University

Thomas Van Cangh

Deputy Head of Unit, European Commission

Diana Čekatauskaitė

Business Development Manager, Synaffix

Tom van Helmond

Partner and Chairman of Life Science and Healthcare Team, Loyens & Loeff

Marlene Végh

CEO, Catalyze

Jon de Vlieger

Strategy Director, Lygature 

Peter Ketelaar

CEO, iPsomics & Chairman, Life Cooperative

Pedro Hermkens

Consultant, Hermkens Pharma Consultancy

Tatjana Josefs

Managing Consultant, Catalyze

Louise Bouman

Patient Representative, Pulmonary Arterial Hypertension Association

Beth DelGiacco

VP, Corporate Communications & Investor Relations, argenx

Ellen Smit

Managing Director, Rotterdam Square

Chretien Herben

External Advisor Valorisation, 
Health~Holland

Hanneke Takkenberg

Professor, Erasmus MC